SAB Biotherapeutics
Price & Volume
Stats
See more52W Range | $1.60-$5.15 |
Market Cap | $256.9M |
Shares Short | 2M |
Financials
See moreRevenue (12 Mos) | $114,698 |
Revenue Growth (YoY) | -62.4% |
Gross Profit (12 Mos) | -$33.3M |
Diluted EPS | -$0.58 |
News
See moreYahoo Finance • 12 days ago
SAB BIO to Present Data on SAB-142 at The American Diabetes Association’s 2026 Scientific Sessions and FOCIS 2026 Annual Meeting
Yahoo Finance • 3 months ago
SAB Biotherapeutics slips 5%, prices $85M stock offering
Yahoo Finance • 3 months ago
SAB BIO Announces Additional Phase 1 Data for SAB-142 in Adult Patients with Established Autoimmune Type 1 Diabetes
About
CEO | Mr. Samuel J. Reich |
CFO | Ms. Lucy To |
Address | 777 W 41st St., Miami Beach, FL, United States, 33140 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 86 |